Hutchmed (China) Limited

Net Asset Value • Aug 8, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2742L

Hutchison China Meditech Limited

08 August 2013

Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Director's Shareholding

London: Thursday, 8 August 2013: Chi-Med received notification on 8 August 2013 that Mr Christopher Nash, Independent Non-executive Director of Chi-Med, purchased 8,506 ordinary shares of US$1.00 each in Chi-Med (the "Shares") at a price of GBP5.84 each on 7 August 2013.

Following this purchase, Mr Nash is beneficially interested in 26,506 Shares, representing approximately 0.05% of the current issued share capital of Chi-Med.

Ends

Enquiries

Chi-Med   Christian Hogg, CEO	Telephone:      +852 2121 8200
Panmure Gordon (UK) Limited    Richard Gray    Andrew Potts    Grishma Patel	Telephone:      +44 20 7886 2500
Citigate Dewe Rogerson   Anthony Carlisle    David Dible	Telephone:      +44 20 7638 9571 Mobile:             +44 7973 611 888 Mobile:             +44 7967 566 919

About Chi-Med

Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBBGDISGGBGXI